TY - JOUR
T1 - RNA-binding proteins hnRNPM and ELAVL1 promote type-I interferon induction downstream of the nucleic acid sensors cGAS and RIG-I
AU - Kirchhoff, Alexander
AU - Herzner, Anna Maria
AU - Urban, Christian
AU - Piras, Antonio
AU - Düster, Robert
AU - Mahlberg, Julia
AU - Grünewald, Agathe
AU - Schlee-Guimarães, Thais M.
AU - Ciupka, Katrin
AU - Leka, Petro
AU - Bootz, Robert J.
AU - Wallerath, Christina
AU - Hunkler, Charlotte
AU - de Regt, Ann Kristin
AU - Kümmerer, Beate M.
AU - Christensen, Maria Hønholt
AU - Schmidt, Florian I.
AU - Lee-Kirsch, Min Ae
AU - Günther, Claudia
AU - Kato, Hiroki
AU - Bartok, Eva
AU - Hartmann, Gunther
AU - Geyer, Matthias
AU - Pichlmair, Andreas
AU - Schlee, Martin
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - The cytosolic nucleic acid sensors RIG-I and cGAS induce type-I interferon (IFN)-mediated immune responses to RNA and DNA viruses, respectively. So far no connection between the two cytosolic pathways upstream of IKK-like kinase activation has been investigated. Here, we identify heterogeneous nuclear ribonucleoprotein M (hnRNPM) as a positive regulator of IRF3 phosphorylation and type-I IFN induction downstream of both cGAS and RIG-I. Combining interactome analysis with genome editing, we further uncover the RNA-binding protein ELAV-like protein 1 (ELAVL1; also known as human antigen R, HuR) as an hnRNPM interactor. Depletion of hnRNPM or ELAVL1 impairs type-I IFN induction by herpes simplex virus 1 or Sendai virus. In addition, we show that hnRNPM and ELAVL1 interact with TANK-binding kinase 1, IκB kinase ε, IκB kinase β, and NF-κB p65. Our confocal microscopy experiments demonstrate cytosolic and perinuclear interactions between hnRNPM, ELAVL1, and TBK1. Furthermore, pharmacological inhibition of ELAVL1 strongly reduces cytokine release from type-I interferonopathy patient fibroblasts. The RNA-binding proteins hnRNPM and ELAVL1 are the first non-redundant regulators to bridge the cGAS/STING and RIG-I/MAVS pathways. Overall, our study characterizes the hnRNPM-ELAVL1 complex as a novel system promoting antiviral defense, pointing to a potential therapeutic target to reduce auto-inflammation in patients with type-I interferonopathies.
AB - The cytosolic nucleic acid sensors RIG-I and cGAS induce type-I interferon (IFN)-mediated immune responses to RNA and DNA viruses, respectively. So far no connection between the two cytosolic pathways upstream of IKK-like kinase activation has been investigated. Here, we identify heterogeneous nuclear ribonucleoprotein M (hnRNPM) as a positive regulator of IRF3 phosphorylation and type-I IFN induction downstream of both cGAS and RIG-I. Combining interactome analysis with genome editing, we further uncover the RNA-binding protein ELAV-like protein 1 (ELAVL1; also known as human antigen R, HuR) as an hnRNPM interactor. Depletion of hnRNPM or ELAVL1 impairs type-I IFN induction by herpes simplex virus 1 or Sendai virus. In addition, we show that hnRNPM and ELAVL1 interact with TANK-binding kinase 1, IκB kinase ε, IκB kinase β, and NF-κB p65. Our confocal microscopy experiments demonstrate cytosolic and perinuclear interactions between hnRNPM, ELAVL1, and TBK1. Furthermore, pharmacological inhibition of ELAVL1 strongly reduces cytokine release from type-I interferonopathy patient fibroblasts. The RNA-binding proteins hnRNPM and ELAVL1 are the first non-redundant regulators to bridge the cGAS/STING and RIG-I/MAVS pathways. Overall, our study characterizes the hnRNPM-ELAVL1 complex as a novel system promoting antiviral defense, pointing to a potential therapeutic target to reduce auto-inflammation in patients with type-I interferonopathies.
KW - cGAS Signaling
KW - ELAVL1
KW - hnRNPM
KW - IRF3
KW - RIG-I Signaling
UR - http://www.scopus.com/inward/record.url?scp=85212865879&partnerID=8YFLogxK
U2 - 10.1038/s44318-024-00331-x
DO - 10.1038/s44318-024-00331-x
M3 - Article
AN - SCOPUS:85212865879
SN - 0261-4189
JO - EMBO Journal
JF - EMBO Journal
M1 - 107492
ER -